Immune Cells and Cardiovascular Disease: New Players and Novel Therapeutic Opportunities
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Cardiovascular System".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 290
Special Issue Editor
Special Issue Information
Dear Colleagues,
The complex interplay between the immune system and cardiovascular disease has recently taken center stage. Researchers have discovered that age-related somatic mutations and functional decline of immune cells increase cardiovascular risk. Immune cells can be found in cardiovascular tissue at the earliest pathological stages and often persist throughout the disease course. Their phenotype, however, alters significantly, suggesting that different immune subsets may contribute to disease initiation, progression, and regression. In this issue of Cells, we discuss how both innate and adaptive immune cells promote cardiovascular health and disease, and we introduce novel approaches that modulate immune function to enable disease resolution.
Dr. Patricia Nguyen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adaptive immunity
- innate immunity
- inflammation
- cardiovascular disease
- atherosclerosis
- cardio-immunology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
